Tyson Falls on 3Q Results; Bristol-Myers Squibb Surges on Potential Acquisition | Stock Movers

Bristol-Myers Squibb shares rose after AstraZeneca announced it was exploring an acquisition of the company, while AstraZeneca shares fell. Tyson Foods reported third-quarter sales below expectations, citing a 16% decline in beef sales volume, and reduced its full-year profit forecasts for the company and its beef division. SpaceX shares moved as investors prepared for the company's first earnings report following its public listing.

Next story